Standardizing Computational Simulation Credibility for Regulatory Submissions in Device Science

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Device https://doi.org/10.1016/j.device.2026.101303 
Dr. Yidan Xue et al.

Points

Researchers from the University of Manchester and the MHRA developed a risk informed framework to standardize computer simulation evidence for medical device regulatory decisions.
Historical data indicates that only thirty percent of novel high risk medical devices reach the market while forty percent fail during pivotal clinical trial evaluations.
The framework establishes a risk informed credibility matrix mapping model influence against decision consequences to dictate verification validation and uncertainty quantification rigor.
Application to a transcatheter aortic valve implantation redesign demonstrated how computational modeling evaluates device expansion conduction interference and paravalvular blood leakage.
Authors concluded that validated in silico evidence complements traditional bench testing and clinical trials by expanding safety evaluations across diverse virtual patient populations.

Summary

This study evaluated a novel risk-informed framework for integrating computer-generated in silico evidence into the regulatory evaluation of medical devices. Published in Device by researchers from the University of Manchester, the UK Medicines and Healthcare products Regulatory Agency (MHRA), and industry partners within the UK Centre of Excellence on In Silico Regulatory Science and Innovation (UK CEiRSI), the investigation addressed limitations in conventional bench, animal, and clinical testing. Given that only approximately 30% of high-risk medical devices reach the market and nearly 40% fail in pivotal trials, the research sought to establish standardized parameters for verifying, validating, and establishing the credibility of computational simulations in regulatory submissions.

The multidisciplinary team established a structured decision workflow to select and prioritize device-related harms for in silico modeling based on regulatory relevance, mechanistic plausibility, and incremental evidence value. The framework utilizes a risk-informed credibility matrix that evaluates model influence against decision consequences to dictate the required rigor for verification, validation, and uncertainty quantification (VVUQ). To demonstrate practical utility, the authors applied the framework to a hypothetical redesign of a transcatheter aortic valve implantation (TAVI) device, assessing critical computational endpoints including stent expansion, conduction system interaction, and paravalvular leak.

The authors conclude that integrating validated in silico modeling into regulatory pathways provides a robust, credible mechanism to complement traditional empirical testing. By enabling testing across diverse, large-scale virtual patient populations, this risk-informed approach addresses ethical and practical gaps in clinical trials, particularly for underrepresented demographics such as pediatric and pregnant populations. These evidence-based recommendations establish a standardized framework for manufacturers and international regulatory bodies to accelerate safe device innovation while maintaining rigorous safety standards.

Link to the article: https://www.cell.com/device/fulltext/S2666-9986(26)00255-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666998626002553%3Fshowall%3Dtrue

References

Xue, Y., Sarrami-Foroushani, A., Kreuzer, S., McVeigh, C., Grumbridge, M., Bombien, R., McLaren, A., Pandey, P. K., Ademiloye, A. S., Tyler, P., MacRaild, M., Zakeri, A., Revell, A., Banda, G., Hill, D., Nithiarasu, P., Manfrin, A., De Cunha Maluf-Burgman, M., & Frangi, A. F. (2026). Risk-informed framework for in silico regulatory evaluation of medical devices. Device, 101303. https://doi.org/10.1016/j.device.2026.101303